Compare KRG & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRG | BLCO |
|---|---|---|
| Founded | 1971 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Ophthalmic Goods |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.9B |
| IPO Year | 2004 | 2022 |
| Metric | KRG | BLCO |
|---|---|---|
| Price | $26.08 | $15.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $26.00 | $18.45 |
| AVG Volume (30 Days) | ★ 1.6M | 362.5K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.47% | N/A |
| EPS Growth | ★ 6750.00 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | $844,365,000.00 | ★ $5,101,000,000.00 |
| Revenue This Year | N/A | $8.65 |
| Revenue Next Year | $0.96 | $5.59 |
| P/E Ratio | $18.96 | ★ N/A |
| Revenue Growth | 0.30 | ★ 6.47 |
| 52 Week Low | $20.86 | $10.45 |
| 52 Week High | $26.82 | $18.92 |
| Indicator | KRG | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 42.52 |
| Support Level | $21.84 | $14.27 |
| Resistance Level | $26.29 | $17.11 |
| Average True Range (ATR) | 0.43 | 0.39 |
| MACD | 0.06 | -0.05 |
| Stochastic Oscillator | 64.95 | 18.00 |
Kite Realty Group Trust specializing in high-quality, open-air shopping centers and mixed-use assets. Concentrated in the Sun Belt and strategic gateway markets, the company focuses on grocery-anchored, necessity-based retail. The company generates the majority of its revenue from contractual rents and reimbursement payments received from tenants.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.